| Expression pattern: |
UP |
| Associated gene: |
EIF4A3 |
| Associated microRNA: |
miR-135-5p |
| Biological function: |
Promotes breast cancer cell growth, proliferation, migration, invasion and metastasis; inhibits apoptosis; acts as an oncogene in breast cancer cells; associated with unfavorable prognosis. |
| Molecular mechanism: |
EIF4A3 positively regulates hsa_circ_0088088 biogenesis/expression, and hsa_circ_0088088 acts as a ceRNA by sponging miR-135-5p to promote breast cancer carcinogenesis. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); apoptosis (inhibits); cell cycle (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Cohort Study; Survival Analysis; Bioinformatics Analysis; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; MTT; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot |
| Clinical significance: |
High hsa_circ_0088088 expression is associated with unfavorable prognosis and decreased overall survival in breast cancer patients. |
| Description: |
hsa_circ_0088088 is up-regulated in breast cancer tissues and cell lines, and high expression predicts poor overall survival. Functionally, it promotes breast cancer cell growth, proliferation, migration, invasion and metastasis while suppressing apoptosis. Mechanistically, EIF4A3 positively regulates hsa_circ_0088088 biogenesis/expression, and hsa_circ_0088088 promotes carcinogenesis by sponging miR-135-5p. |
| Confidence score: |
0.7962 |